Central Reinsurance Corporation:企業の戦略・SWOT・財務情報

◆英語タイトル:Central Reinsurance Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C11601
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Central Reinsurance Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Central Reinsurance Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Central Reinsurance Corporation (Central Re) is a financial institution focused on underwriting reinsurance products and services. The company offers a range of life and non-life reinsurance products to its customers. Its portfolio of non-life reinsurance products include fire reinsurance, marine and aviation reinsurance, motor reinsurance, engineering reinsurance, residential earthquake reinsurance and casualty reinsurance. The life reinsurance products offered by the company include health reinsurance, personal accident reinsurance and life reinsurance. In addition, the company provides risk management services. Central Re primarily operates in Taiwan and other Asian markets such as China, Japan and South Korea. Central Re is headquartered in Taipei, Taiwan.

Central Re reported gross written premium (GWP) of TWD14,041.7 million in FY2016, representing an annual declineof 1.1%.

Scope

- Detailed information on Central Reinsurance Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Central Reinsurance Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Central Reinsurance Corporation including a breakdown and examination of key business segments
- Intelligence on Central Reinsurance Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Central Reinsurance Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Central Reinsurance Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Central Reinsurance Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Central Reinsurance Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Central Reinsurance Corporation: Company Overview 6
Central Reinsurance Corporation: Overview and Key Facts 6
Central Reinsurance Corporation: Overview 6
Central Reinsurance Corporation: Key Facts 6
Central Reinsurance Corporation: Key Employees 8
Central Reinsurance Corporation: Key Employee Biographies 9
Central Reinsurance Corporation: Major Products and Services 10
Central Reinsurance Corporation: Company History 11
Central Reinsurance Corporation: Management Statement 13
Central Reinsurance Corporation: Key Competitors 14
Central Reinsurance Corporation: Company Analysis 15
Central Reinsurance Corporation: Business Description 15
Central Reinsurance Corporation: SWOT Analysis 16
Central Reinsurance Corporation: SWOT Overview 16
Central Reinsurance Corporation: Strengths 16
Central Reinsurance Corporation: Weaknesses 17
Central Reinsurance Corporation: Opportunities 17
Central Reinsurance Corporation: Threats 18
Appendix 19
Contact Us 19
Methodology 19
About MarketLine 20

List of Tables
Table 1: Central Reinsurance Corporation: Key Facts
Table 2: Central Reinsurance Corporation: Key Employees
Table 3: Central Reinsurance Corporation: Company History
Table 4: Central Reinsurance Corporation: Key Competitors



★海外企業調査レポート[Central Reinsurance Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • XERIS Pharmaceuticals Inc (XERS):医療機器:M&Aディール及び事業提携情報
    Summary XERIS Pharmaceuticals Inc (XERIS) is a specialty pharmaceutical company that develops and commercializes injectable and infusible drug formulations. The company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of ultra concentr …
  • Deluxe Corporation:企業の戦略・SWOT・財務情報
    Deluxe Corporation - Strategy, SWOT and Corporate Finance Report Summary Deluxe Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cochin Shipyard Ltd (COCHINSHIP):企業の財務・戦略的SWOT分析
    Cochin Shipyard Ltd (COCHINSHIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Casey’s General Stores, Inc. (CASY):企業の財務・戦略的SWOT分析
    Casey's General Stores, Inc. (CASY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Immco Diagnostics Inc-製薬・医療分野:企業M&A・提携分析
    Summary IMMCO Diagnostics Inc (IMMCO), a subsidiary of Trinity Biotech Plc is a biotechnology company that offers autoimmune disease diagnostic solutions. The company offers a wide range of IFAs, EIAs, Line Immunoassays and Western Blots for an extensive variety of autoimmune disorders. It also deve …
  • Uelzena eG:企業の戦略・SWOT・財務情報
    Uelzena eG - Strategy, SWOT and Corporate Finance Report Summary Uelzena eG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • E. Bon Holdings Limited (599):企業の財務・戦略的SWOT分析
    E. Bon Holdings Limited (599) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Nippon Soda Co., Ltd. (4041):企業の財務・戦略的SWOT分析
    Nippon Soda Co., Ltd. (4041) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • N V Nederlandse Gasunie:企業の戦略・SWOT・財務分析
    N V Nederlandse Gasunie - Strategy, SWOT and Corporate Finance Report Summary N V Nederlandse Gasunie - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • KARL STORZ GmbH & Co KG-医療機器分野:企業M&A・提携分析
    Summary KARL STORZ GmbH & Co KG (Karl Storz) is a manufacturer and distributor of endoscopes, surgical devices and medical instruments. The company offers rigid and flexible endoscopes, instruments for the field of human medicine used for neurosurgery; oral and maxillofacial surgery; ear, nose, and …
  • HudBay Minerals Inc:企業のM&A・事業提携・投資動向
    HudBay Minerals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HudBay Minerals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Hydro Ottawa Holding Inc:企業の戦略的SWOT分析
    Hydro Ottawa Holding Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Glory Ltd
    Glory Ltd - Strategy, SWOT and Corporate Finance Report Summary Glory Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Natrix Separations Inc-製薬・医療分野:企業M&A・提携分析
    Summary Natrix Separations Inc (Natrix), formerly Nysa Membrane Technologies is a medical device company that provides disposable products. The company’s products line comprise HD-Q membrane adsorbers and bind-elute products. Its HD-Q membrane adsorbers finds application in single-use flow-through p …
  • TSO3 Inc (TOS):医療機器:M&Aディール及び事業提携情報
    Summary TSO3 Inc (TSO3) designs develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization processes used in hospitals. The co …
  • bebe stores, inc.:企業の戦略・SWOT・財務分析
    bebe stores, inc. - Strategy, SWOT and Corporate Finance Report Summary bebe stores, inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • GBST Holdings Limited (GBT):企業の財務・戦略的SWOT分析
    GBST Holdings Limited (GBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Dexia Group:企業のM&A・事業提携・投資動向
    Dexia Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dexia Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Cipla Ltd (CIPLA):企業の財務・戦略的SWOT分析
    Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • AZTherapies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary AZTherapies Inc (AZTherapies) is a clinical-stage drug development company that offers discovery, development and commercialization of novel Alzheimer’s disease therapeutics. The company’s product pipeline includes the lead product candidate ALZT-OP1, besides ALZT-Patch, ALZT-QoL, AZHALER-D …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆